BioSpace News Archive

X4 Pharmaceuticals, Inc. today announced that management will conduct one-on-one investor meetings at the Citi 16th Annual BioPharma Conference and participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, announces that the last patient has been enrolled and safely dosed in Stage 2 of Part B of its Phase II TACTI-002 study (also designated KEYNOTE-798).

Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (“Coherus”, Nasdaq: CHRS) announced today the completion of the rolling submission of the Biologics License Application (“BLA”) to the U.S. Food and Drug Administration (“FDA”) for toripalimab.

Akebia Therapeutics, Inc. today announced that John P. Butler , Chief Executive Officer, and David A. Spellman , Chief Financial Officer, will participate in the following schedule of investor conferences.

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT.

Pillar Biosciences today announced the appointment of Randy Pritchard as Chief Executive Officer.

Bryn Pharma, LLC today announced the appointment of Anne Clem Whitaker to its Board of Directors, effective immediately.

InterVenn Biosciences today announced that it will be participating via webcast in the Morgan Stanley 19th Annual Global Healthcare Conference.

Lineage Cell Therapeutics, Inc. today announced that it has appointed George A. Samuel III as Lineage’s General Counsel and Corporate Secretary.

Entera Bio Ltd. today announced it has been selected by the 2021 Program Committee of the American Society for Bone and Mineral Research (ASBMR) Annual Meeting for a late breaking oral presentation.